The stock market continues to drift back below the short term moving averages in a flag type pattern ahead of the beginning of earning season, which gets underway on this week with some major financials reporting on Thursday and Friday...

One of the hardest aspects of Stan Weinstein's Stage Analysis method is identifying when a stock / etf / index etc is transitioning from one Stage to another. The Stage Analysis Investor method entry points are at the Stage 2 breakout point, and on a successful backup to the Stage 2 breakout following the breakout...

In this weeks Stage Analysis Members video we look at the in-focus group – Biotechnology, which has been showing a lot of relative strength in the short term as it attempts to rebound from a deep Stage 4 decline back into potential Stage 1, and look at a few of the strongest stocks from the group...

For the watchlist from the weekend scans...

For the watchlist from Thursdays scans...

Midweek video covering the Stage 2 breakout attempt in CELH. Plus an In Focus segment on the Biotech (XBI) and Chinese (FXI) ETFs. Followed by the Major Indexes Update – S&P 500, Nasdaq Composite and Russell 2000, and short term Market Breadth charts, and then an in-depth run through of the recent US Watchlist Stocks...

A mixed day in the stock market with the NYSE stocks down while the Nasdaq stocks were up. So rotation was the theme with money flowing out of the stronger RS areas, such as the Coal stocks, with the group chart now approaching its 200 day MA and moving into Stage 3...

The Stage Analysis Members Weekend Video this week covers the Major Indexes with analysis of S&P 500, Nasdaq, Russell 2000, as well as Oil, Copper, US 7-10 Year Treasuries & Gold...

The S&P 500 percentage of stocks above their 20 day exponential moving averages closed the week at 42.40% with an attempt to make a high low after reaching the most extreme reading since March 2020 earlier in June...

The stock market saw strong moves on Friday with the 5th attempt at a Follow Through Day (FTD) forming of this Stage 4 decline, which coincided with other short-term signals...